Last 0.45 MYR
Change Today +0.005 / 1.14%
Volume 1.1M
TMCL On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 4:51 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

tmc life sciences bhd (TMCL) Snapshot

Open
0.45
Previous Close
0.44
Day High
0.45
Day Low
0.44
52 Week High
07/16/14 - 0.47
52 Week Low
08/28/13 - 0.37
Market Cap
357.1M
Average Volume 10 Days
3.3M
EPS TTM
0.01
Shares Outstanding
802.4M
EX-Date
11/6/13
P/E TM
41.8x
Dividend
0.0030
Dividend Yield
0.67%
Current Stock Chart for TMC LIFE SCIENCES BHD (TMCL)

Related News

No related news articles were found.

tmc life sciences bhd (TMCL) Related Businessweek News

No Related Businessweek News Found

tmc life sciences bhd (TMCL) Details

TMC Life Sciences Berhad, an investment holding company, primarily operates a multi-disciplinary tertiary care centre and fertility center in Malaysia. The company’s tertiary care centre provides healthcare services in various medical/surgical specialties and subspecialties, including anaesthesiology, obstetrics and gynaecology, ophthalmology, cardiology, dermatology, endocrinology, gastroenterology, fertility, hepatology, internal medicine, nephrology, paediatrics, psychiatry, radiology and interventional radiology, respiratory medicine, and urology, as well as breast and endocrine, cancer, cardiothoracic, colorectal, ENT, head and neck laser, general and minimally invasive, hepatobiliary, neuro, hand and micro, oral and maxillofacial, orthopaedic, plastic and reconstructive, vascular and endovascular, and upper gastrointestinal surgeries. Its fertility center provides a range of fertility treatments for couples. The company also operates a women’s clinic; provides consultancy, laboratory, and embryology services; and offers gynaecological and fertility problem management services. In addition, it is involved in developing, marketing, and managing healthcare programs; and marketing and promoting healthcare products; and research and development, and property investment activities. TMC Life Sciences Berhad was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.

Founded in 2003

tmc life sciences bhd (TMCL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tmc life sciences bhd (TMCL) Key Developments

TMC Life Sciences Berhad Proposes Single-Tier Final Dividend for the Year Ended 31 May 2014

The Board of Directors of TMC Life Sciences Berhad proposed a single-tier final dividend of 3% for the financial year ended 31 May 2014 to the shareholders for approval at the forthcoming annual general meeting.

TMC Life Sciences Berhad Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended May 31, 2014

TMC Life Sciences Berhad reported unaudited consolidated earnings results for the fourth quarter and full year ended May 31, 2014. For the quarter, revenue was MYR 24,216,000 against MYR 20,569,000 a year ago. Profit from operations was MYR 4,606,000 against MYR 2,584,000 a year ago. Interest income was MYR 215,000 against MYR 153,000 a year ago. Profit before tax was MYR 2,803,000 against MYR 850,000 a year ago. Profit after taxation from continuing operations was MYR 2,681,000 or 0.22 sen per diluted share against MYR 923,000 or 0.08 sen per diluted share a year ago. Profit after taxation was MYR 2,681,000 against MYR 923,000 a year ago. Profit attributable to owners of the parent was MYR 2,681,000 or 0.22 sen per diluted share against MYR 923,000 or 0.08 sen per diluted share a year ago. Revenue grew 18% compared to the previous corresponding quarter mainly driven by higher patient load arising from additional bed capacity and more variety of disciplines offered. Profitability improved due to higher revenue recorded. For the full year, revenue was MYR 88,132,000 against MYR 72,221,000 a year ago. Profit from operations was MYR 13,957,000 against MYR 9,383,000 a year ago. Interest income was MYR 780,000 against MYR 391,000 a year ago. Profit before tax was MYR 6,740,000 against MYR 2,103,000 a year ago. Profit after taxation from continuing operations was MYR 6,457,000 or 0.54 sen per diluted share against MYR 2,177,000 or 0.18 sen per diluted share a year ago. Profit after taxation was MYR 6,457,000 against MYR 11,081,000 a year ago. Profit attributable to owners of the parent was MYR 6,486,000 or 0.54 sen per diluted share against MYR 11,122,000 or 0.92 sen per diluted share a year ago. Net cash flows from operating activities were MYR 11,639,000 against MYR 8,072,000 a year ago. Acquisition of property plant and equipment was MYR 3,274,000 against MYR 3,871,000 a year ago. The Group recorded 22% growth in revenue for the financial year ended 31 May 2014 compared with the previous financial year. The growth was contributed by additional bed capacity and more variety of services offered coupled with continuing marketing activities. The Group recorded higher profit before tax for the current financial year mainly attributable to higher revenue achieved.

TMC Life Sciences Berhad Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended February 28, 2014

TMC Life Sciences Berhad announced unaudited consolidated earnings results for the third quarter and nine months ended February 28, 2014. For the quarter, the company reported revenue was MYR 22,109,000 against MYR 17,733,000 a year ago, mainly due to higher patient load supported by additional bed capacity and more variety of disciplines offered. Profit from operations was MYR 3,527,000 against MYR 2,067,000 a year ago. Profit before taxation was MYR 1,740,000 against MYR 278,000 a year ago. Profit from continuing operations was MYR 1,743,000 against MYR 261,000 a year ago. Profit attributable to owners of the parent was MYR 1,743,000 against MYR 2,834,000 a year ago. Diluted earnings per share from continuing operations was 0.14 sen against 0.02 sen a year ago. Diluted earnings per share was 0.14 sen against 0.24 sen a year ago. Profitability improved due to higher revenue recorded. For the nine months, the company reported revenue was MYR 63,916,000 against MYR 51,652,000 a year ago. The growth was contributed by additional bed capacity and more variety of services offered coupled with continuing marketing activities. Profit from operations was MYR 9,351,000 against MYR 6,784,000 a year ago. Profit before taxation was MYR 3,937,000 against MYR 1,253,000 a year ago. Profit before tax was mainly attributable to higher revenue achieved. Profit from continuing operations was MYR 3,776,000 against MYR 1,254,000 a year ago. Profit attributable to owners of the parent was MYR 3,776,000 against MYR 10,158,000 a year ago. Diluted earnings per share from continuing operations was 0.31 sen against 0.10 sen a year ago. Diluted earnings per share was 0.31 sen against 0.84 sen a year ago. Net cash flows from operating activities was MYR 7,985,000 against MYR 4,762,000 a year ago. Acquisition of property plant and equipment was MYR 2,793,000 against MYR 1,836,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMCL:MK 0.45 MYR +0.005

TMCL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TMCL.
View Industry Companies
 

Industry Analysis

TMCL

Industry Average

Valuation TMCL Industry Range
Price/Earnings 83.1x
Price/Sales 4.1x
Price/Book 2.6x
Price/Cash Flow 24.9x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TMC LIFE SCIENCES BHD, please visit www.tmclife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.